April 22, 2021
Delaware Connections Run Deep As DuPont Family's Darla Pomeroy Heads To Treasury
Darla Pomeroy, who is married to an heir to the DuPont family fortune, was just named Senior Advisor to the Office of Domestic Finance at the US Treasury. While her record does not show any familiarity with financial regulatory policy, it reveals instead a history of a powerful corporation highly influential in Delaware placing a close ally in the administration.
April 22, 2021
Wall Street Lawyer Leading Wall Street Oversight Unsettles Allies Of Gensler
“Oh has chosen to spend over 20 years reinforcing a corrupt status quo in corporate America, in which the largest companies systematically evade democratic accountability. No one so comfortable with the breakdown in the rule of law over corporate America should be entrusted with responsibility for implementing long-overdue accountability on Wall Street.”
April 21, 2021
Education Department Must Rein In For-Profit College Industry Mergers And Reclassifications
The Education Department controls almost every aspect of regulating for-profits, from certifying the accrediting agencies to the enforcement of student protections like the gainful employment rule and the borrower defense rule.
April 21, 2021
Watchdog Grades Biden A "B-" On Preventing Corporate Capture Of Executive Branch
“Although the bar is low, Biden has proven to be the least captured and most public-oriented President of any of our lifetimes,” the Revolving Door Project wrote. “That said, Biden’s administration thus far is certainly not spotless.”
April 16, 2021
The Brother Of A Pharma Lobbyist Advises Biden As He Weighs Vaccine IP Waiver
Despite pushback from progressives, Ricchetti has continued to hold a powerful advisory position in the Biden White House. His background in corporate lobbying and strong ties to the pharmaceutical industry are deeply troubling signs as the Biden Administration faces enormously consequential decisions about how to end the COVID-19 pandemic.
April 14, 2021
Big Pharma's Coils Around COVID-19 Vaccines Likely Protected By Raimondo, Zients, Ricchetti
The world deserves to know exactly who is responsible for the United States not yet supporting a waiver for intellectual property rights on COVID-19 vaccine production.
April 08, 2021
Blog Post CabinetDepartment of JusticeEthics in GovernmentExecutive BranchRevolving DoorRight-Wing MediaTreasury Department
Biden Cabinet Confirmations Show Continued Political Potency Of Revolving Door Critiques
The prolonged confirmation fights for top Biden nominees proved one thing: Republicans will gleefully and cynically exploit anti-corruption critiques of Biden’s Cabinet for their own political purposes. The President must deny them this potent political weapon by closing corporate America’s revolving door for good.
April 02, 2021 | The American Prospect
Dorothy Slater Eleanor Eagan Max Moran
Op-Ed ClimateExecutive BranchFinancial RegulationLarry Summers
Janet Yellen's Blind Spot On Regulation
With so many competing priorities, it’s justifiable that Yellen has not given her full attention to every single crisis under her purview. But she can no longer dodge her other big duty: financial policy and Wall Street regulation.
March 29, 2021
White House Personal Financial Disclosures
The Revolving Door Project has been requesting personal financial disclosures, or Form 278e’s, since the White House made them available. While we are still waiting to receive many requests back, we wanted to share the ones we have received with the public as quickly as possible by summarizing relevant findings for each White House appointee.
March 29, 2021
Pharma In The White House: Financial Disclosures Reveal Officials' Stake In Vaccine Manufacturers
Financial disclosures revealed that numerous high level Biden White House officials have financial holdings in vaccine manufacturers, while some of them are involved in vaccine distribution talks.
March 29, 2021 | The American Prospect
Toward a Conflict-of-Interest-Free West Wing
The latest batch of White House financial disclosures revealed close ties between top Biden Administration officials and corporate titans in Big Tech, Big Oil, and Big Pharma. Eleanor Eagan and Elias Alsbergas explain why these disclosures reveal the need for the Biden White House to adopt stronger ethics disclosures and mandate total divestment from potential conflicts of interest.
March 23, 2021
Revolver Spotlight: Elizabeth Rosenberg
Elizabeth Rosenberg, a lesser-known Obama-era official, is being considered to lead the Treasury Department’s Terrorism and Financial Intelligence unit. Her record designing painful economic sanctions, supporting fossil fuel industry-friendly policies, and helping powerful corporations gain close access to the highest levels of government is cause for alarm, writes Vishal Shankar.
March 22, 2021 | Democracy Journal
Building Back Better (Than Expected)
The nominations that President Biden has made thus far serve as a guidebook to the years ahead. By analyzing those picks, we see a vivid picture of where we can expect strong executive actions to take on the corporate monopolies and polluters choking the American economy—and where we can anticipate division between the progressive base and corporatist establishment actors.
March 22, 2021 | TruthOut
We Need An Interior Department Aimed At Environmental Justice — Not Destruction
With Haaland at its head, the DOI will have a real chance to reverse its role in exacerbating climate change and environmental racism. Yet, in order to fully realize this potential, the agency will need more funding, increased lower-level staff and much more diversity.
March 18, 2021
Congress Must Examine Biden Admin Possibly Trading Vaccines For Anti-Migration Enforcement
The Revolving Door Project is outraged by yesterday’s news that the Biden administration has been pressuring the Mexican government into turning away migrants at the Mexico-Guatemala border. While this Trump style initiative would be appalling on its own, we are additionally concerned about the possibility that President Biden may have bartered millions of doses of the AstraZeneca vaccine to achieve his anti-migration goals.